• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伊维菌素治疗后罗阿丝虫抗原的释放]

[Release of Loa loa antigens after treatment with ivermectin].

作者信息

Chippaux J P, Nkinin S W, Gardon-Wendel N, Ducorps M

机构信息

ORSTOM, Centre Pasteur du Cameroun.

出版信息

Bull Soc Pathol Exot. 1998;91(4):297-9.

PMID:9846220
Abstract

This study concerns 112 patients of whom 104 were followed up. Microfilaricidal treatment of loaiasis is sometimes followed by severe adverse reactions. Using an immunodiffusion technique and the measure of microfilaraemia by calibrated thick smear, the authors show that the intensity of adverse reactions is proportional to the quantity of microfilariae eliminated by the treatment. The appearance of Loa loa antigens within three days following treatment was evident in 83% of the subjects. Five patients presenting the serious adverse reactions described belonged to this group. However, the precise cause of these adverse reactions, allergic or toxic, has not been demonstrated.

摘要

本研究涉及112例患者,其中104例接受了随访。罗阿丝虫病的微丝蚴杀灭治疗有时会伴有严重不良反应。作者采用免疫扩散技术并通过校准厚涂片测量微丝蚴血症,结果表明不良反应的强度与治疗清除的微丝蚴数量成正比。83%的受试者在治疗后三天内出现明显的罗阿丝虫抗原。出现所述严重不良反应的5例患者属于该组。然而,这些不良反应的确切原因,无论是过敏还是中毒,尚未得到证实。

相似文献

1
[Release of Loa loa antigens after treatment with ivermectin].[伊维菌素治疗后罗阿丝虫抗原的释放]
Bull Soc Pathol Exot. 1998;91(4):297-9.
2
[Nephropathy and filariasis from Loa loa. Apropos of 1 case of adverse reaction to a dose of ivermectin].
Bull Soc Pathol Exot. 1997;90(3):179-81.
3
[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].[使用伊维菌素治疗高微丝蚴血症盘尾丝虫病的继发效应]
Bull Soc Pathol Exot. 1995;88(3):105-12.
4
Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.喀麦隆中部省份罗阿丝虫感染的流行率与感染强度之间的关系。
Ann Trop Med Parasitol. 2001 Jul;95(5):495-507. doi: 10.1080/00034980120073184.
5
Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.用伊维菌素治疗高盘尾丝虫微丝蚴血症患者后的眼部表现。
Ophthalmic Epidemiol. 2000 Mar;7(1):27-39.
6
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.伊维菌素治疗患者中罗阿罗阿微丝蚴的周期性:发生和无严重不良事件者的比较。
Am J Trop Med Hyg. 2009 Dec;81(6):1056-61. doi: 10.4269/ajtmh.2009.09-0356.
7
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.在罗阿丝虫感染流行地区用伊维菌素大规模治疗盘尾丝虫病后的严重反应。
Lancet. 1997 Jul 5;350(9070):18-22. doi: 10.1016/S0140-6736(96)11094-1.
8
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).伊维菌素治疗罗阿丝虫微丝蚴血症的随机对照双盲试验:低剂量(约25微克/千克)与现行标准剂量(150微克/千克)的疗效比较
Trans R Soc Trop Med Hyg. 2007 Aug;101(8):777-85. doi: 10.1016/j.trstmh.2007.03.018. Epub 2007 May 24.
9
Rapid assessment method for prevalence and intensity of Loa loa infection.罗阿丝虫感染患病率和感染强度的快速评估方法。
Bull World Health Organ. 2002;80(11):852-8. Epub 2002 Dec 3.
10
A novel antigen biomarker for detection of high-level of Loa loa microfilaremia.一种用于检测高水平罗阿罗阿微丝蚴的新型抗原生物标志物。
PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012461. doi: 10.1371/journal.pntd.0012461. eCollection 2024 Sep.

引用本文的文献

1
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.喀麦隆大规模伊维菌素治疗盘尾丝虫病相关罗阿丝虫严重不良事件的临床表现、流行病学及结局
Filaria J. 2003 Oct 24;2 Suppl 1(Suppl 1):S4. doi: 10.1186/1475-2883-2-S1-S4.